Featured Research

from universities, journals, and other organizations

Tide is turning in skin cancer battle

Date:
July 16, 2013
Source:
Michigan State University
Summary:
Recent advances have put melanoma at the forefront of cancer research, raising hopes that scientists and clinicians may have cornered the deadliest of all skin cancers.

Brian Nickoloff, who leads melanoma research in MSU's College of Human Medicine, with medical student Eileen Larkin. They are among the authors of a new paper arguing that scientists are beginning to gain the upper hand against the deadly skin cancer. Photo by John Corriveau.

A decade ago there was little doctors could do to help a patient with advanced-stage melanoma.

Now it seems each week yields important new discoveries about the deadly skin cancer.

"I've been doing this for 30 years, and now is by any measure the most exciting time for melanoma research," said Brian Nickoloff, director of the Nicholas V. Perricone, M.D., Division of Dermatology and Cutaneous Sciences at Michigan State University's College of Human Medicine.

In the research journal Laboratory Investigation, Nickoloff and colleagues outline recent advances that have put melanoma at the forefront of cancer research, raising hopes that scientists and clinicians may have cornered the deadliest of all skin cancers.

"In the past melanoma outsmarted us, but now we're starting to outsmart melanoma," said Nickoloff, who also is director of cutaneous oncology at Van Andel Research Institute in Grand Rapids and a member of the Stand Up to Cancer Dream Team for melanoma research. "Go back 10 years and you'll see we had almost nothing to offer patients with advanced disease, but now we're definitely getting the upper hand on this cancer."

Melanoma is really a catch-all term for the most virulent types of skin cancer. The disease's complexity is staggering -- melanoma tumors have more mutations per cell than any other type of cancer -- but new diagnostic tools such as DNA sequencing are helping scientists sort through troves of data to decode each tumor's "fingerprint."

And while the list of known mutations that cause melanoma keeps growing, researchers can target most of them by blocking a handful of the "signaling pathways" that control normal cell function and can cause tumors to form and spread.

Meanwhile, about 100 new drugs with melanoma in their sights are in development, and new combinations of drugs show promise for blocking cancer-causing signaling pathways.

Still, optimism about such progress is tempered by the fact that someone dies from melanoma every hour. Besides being deadly, melanoma is one of the fastest growing cancers worldwide. Melanoma also is unusual among cancers in how often it develops in young people; it is one of the leading causes of cancer-related deaths in 25- to 29-year-old women.

Science's rapid progress in understanding and treating melanoma must be coupled with prevention efforts to educate people about the dangers of sun exposure and artificial tanning, Nickoloff said.

"It's entirely preventable," he said. "Nobody should die from advanced-stage melanoma."

Education was part of the goal of the College of Human Medicine's Gran Fondo, a June bicycling event in Grand Rapids that in its first year attracted 1,500 cyclists and raised about $100,000 for MSU melanoma research.

Nickoloff said that community support is matched by an increasingly collaborative research atmosphere in Grand Rapids -- his co-authors on the new paper included Michigan State medical students and cancer experts from Van Andel and Mercy Health Saint Mary's -- that will keep MSU and its West Michigan partners at the leading edge of melanoma research.

"I wish I were 20 years younger, because we're going to see more and more long-term remissions," he said. "We'll get better every year we're at this."


Story Source:

The above story is based on materials provided by Michigan State University. Note: Materials may be edited for content and length.


Journal Reference:

  1. Jose M Pimiento, Eileen M Larkin, Keiran SM Smalley, Ginger L Wiersma, Noel R Monks, Inna V Fedorenko, Chelsea A Peterson, Brian J Nickoloff. Melanoma genotypes and phenotypes get personal. Laboratory Investigation, 2013; DOI: 10.1038/labinvest.2013.84

Cite This Page:

Michigan State University. "Tide is turning in skin cancer battle." ScienceDaily. ScienceDaily, 16 July 2013. <www.sciencedaily.com/releases/2013/07/130716120102.htm>.
Michigan State University. (2013, July 16). Tide is turning in skin cancer battle. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2013/07/130716120102.htm
Michigan State University. "Tide is turning in skin cancer battle." ScienceDaily. www.sciencedaily.com/releases/2013/07/130716120102.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins